With all the recent studies of medical marijuana and its benefits, some researchers have become interested in researching the use of psychedelics like psilocybin, LSD, and MDMA for treating mental illness. It’s hard to research though, because of the drugs’ legal status as Schedule I drugs. This makes them very hard for researchers to obtain, it makes it hard to get research approved, and it make it difficult to find funding for these studies. We’ve got the details.
This episode was adapted from a column I wrote for The Upshot. Links to sources and further reading can be found there.